These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18029870)

  • 21. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial fibrosis in a patient with apical hypertrophic cardiomyopathy detected by delayed-enhanced magnetic resonance imaging.
    Sato Y; Matsumoto N; Kunimasa T; Matsuo S; Yoda S; Tani S; Kunimoto S; Saito S; Hirayama A
    Int J Cardiol; 2008 Dec; 131(1):e41-3. PubMed ID: 17920709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.
    Maron MS; Appelbaum E; Harrigan CJ; Buros J; Gibson CM; Hanna C; Lesser JR; Udelson JE; Manning WJ; Maron BJ
    Circ Heart Fail; 2008 Sep; 1(3):184-91. PubMed ID: 19808288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Patterns of delayed-enhancement in MRI of ischemic and non-ischemic cardiomyopathies].
    Stork A; Müllerleile K; Bansmann PM; Koops A; Meinertz T; Adam G; Lund GK
    Rofo; 2007 Jan; 179(1):21-30. PubMed ID: 17203440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Differentiation of hypertrophic cardiomyopathy from left ventricular hypertrophy induced by essential hypertension using magnetic resonance imaging].
    Doyoshita H; Murakami E; Takekoshi N; Matsui S; Nakato H; Enyama H
    J Cardiol; 1988 Mar; 18(1):113-9. PubMed ID: 2975702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffuse diseases of the myocardium: MRI-pathologic review of cardiomyopathies with dilatation.
    Giesbrandt KJ; Bolan CW; Shapiro BP; Edwards WD; Mergo PJ
    AJR Am J Roentgenol; 2013 Mar; 200(3):W274-82. PubMed ID: 23436872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hypertrophic cardiomyopathy].
    Scheffold T; Binner P; Erdmann J; Schunkert H;
    Herz; 2005 Sep; 30(6):550-7. PubMed ID: 16170688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
    Rudolph A; Abdel-Aty H; Bohl S; Boyé P; Zagrosek A; Dietz R; Schulz-Menger J
    J Am Coll Cardiol; 2009 Jan; 53(3):284-91. PubMed ID: 19147047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of imaging in evaluation of sudden cardiac death risk in hypertrophic cardiomyopathy.
    Geske JB; Ommen SR
    Curr Opin Cardiol; 2015 Sep; 30(5):493-9. PubMed ID: 26154072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy.
    O'Mahony C; Tome-Esteban M; Lambiase PD; Pantazis A; Dickie S; McKenna WJ; Elliott PM
    Heart; 2013 Apr; 99(8):534-41. PubMed ID: 23339826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy.
    Miller MA; Gomes JA; Fuster V
    Nat Clin Pract Cardiovasc Med; 2007 Dec; 4(12):667-76. PubMed ID: 18033231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
    Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
    J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.
    O'Hanlon R; Grasso A; Roughton M; Moon JC; Clark S; Wage R; Webb J; Kulkarni M; Dawson D; Sulaibeekh L; Chandrasekaran B; Bucciarelli-Ducci C; Pasquale F; Cowie MR; McKenna WJ; Sheppard MN; Elliott PM; Pennell DJ; Prasad SK
    J Am Coll Cardiol; 2010 Sep; 56(11):867-74. PubMed ID: 20688032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Magnetic resonance imaging in hypertrophic cardiomyopathy (preliminary experience of 6 cases)].
    Zhang L
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Feb; 18(1):13-4, 60-1. PubMed ID: 2397688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interventional treatment in hypertrophic cardiomyopathy].
    Gietzen FH; Schümmelfeder J; Neuser H; Brunn J; Schumacher B; Kerber S
    Herz; 2005 Mar; 30(2):102-10. PubMed ID: 15875098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolated left ventricular non-compaction: an unusual indication for heart transplantation.
    Fan KY; Chan CW; Cheng LC; Ko RL; Lam YM; Jim MH; Au TW; Ho CK; Wang EP; Chau EM; Chow WH
    Hong Kong Med J; 2009 Oct; 15(5):378-80. PubMed ID: 19801696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
    Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptomatic ventricular tachyarrhythmia is associated with delayed gadolinium enhancement in cardiac magnetic resonance imaging and with elevated plasma brain natriuretic peptide level in hypertrophic cardiomyopathy.
    Oka K; Tsujino T; Nakao S; Lee-Kawabata M; Ezumi A; Masai M; Ohyanagi M; Masuyama T
    J Cardiol; 2008 Oct; 52(2):146-53. PubMed ID: 18922389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The emerging role of cardiovascular MRI for risk stratification in hypertrophic cardiomyopathy.
    Hoey ET; Teoh JK; Das I; Ganeshan A; Simpson H; Watkin RW
    Clin Radiol; 2014 Mar; 69(3):221-30. PubMed ID: 24412355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.